PMV Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
PMV Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2020 to Q3 2024.
  • PMV Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 6, 2024 was 51.7M shares, a 1.15% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 51.7M +589K +1.15% Nov 6, 2024 10-Q 2024-11-07
Q2 2024 51.5M +3.07M +6.33% Aug 7, 2024 10-Q 2024-08-08
Q1 2024 51.4M +5.67M +12.4% Feb 28, 2024 10-K 2024-02-29
Q3 2023 51.2M +5.49M +12% Nov 7, 2023 10-Q 2023-11-09
Q2 2023 48.5M +2.83M +6.21% Aug 7, 2023 10-Q 2023-08-09
Q1 2023 45.8M +323K +0.71% Feb 24, 2023 10-K 2023-03-01
Q3 2022 45.7M +285K +0.63% Nov 8, 2022 10-Q 2022-11-08
Q2 2022 45.6M +331K +0.73% Aug 9, 2022 10-Q 2022-08-09
Q1 2022 45.5M +668K +1.49% Feb 25, 2022 10-K 2022-03-01
Q3 2021 45.4M +607K +1.36% Nov 10, 2021 10-Q 2021-11-12
Q2 2021 45.3M Aug 12, 2021 10-Q 2021-08-13
Q1 2021 44.8M Feb 28, 2021 10-K 2021-03-03
Q3 2020 44.8M Nov 1, 2020 10-Q 2020-11-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.